Ischemic Stroke

Neurology·MeSH: Ischemic Stroke

Prevalence

1008.3 / 100K

Incidence

109.6 / 100K/yr

31 drugs in development·17 companies·15 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(5)

Drug	Company
milvexian	GH Research PLC (GHRS)
Milvexian	BRISTOL MYERS SQUIBB CO (BMY)
tak-755	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-755	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Tenecteplase	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(15)

Drug	Company
Acetylcysteine	Structure Therapeutics Inc. (GPCR)
Acetylcysteine	Cidara Therapeutics, Inc. (CDTX)
Acetylcysteine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Acetylcysteine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Acetylcysteine	Filana Therapeutics Inc. (FLNA)
Albumin infusion	Cidara Therapeutics, Inc. (CDTX)
Capsaicin Transmucosal Oral Film	Valneva SE (VALN)
Dextrose in Water	Structure Therapeutics Inc. (GPCR)
Dextrose in Water	Cidara Therapeutics, Inc. (CDTX)
Dextrose in Water	PROTHENA CORP PUBLIC LTD CO (PRTA)
Dextrose in Water	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Dextrose in Water	Filana Therapeutics Inc. (FLNA)
MSC	Accustem Sciences Inc. (ACUT)
TAK-755	Merus N.V. (MRUS)
Tenecteplase	Valneva SE (VALN)

Phase 1(2)

Drug	Company
mycophenolate acid	Cidara Therapeutics, Inc. (CDTX)
Peripheral Blood Stem Cell Infusion	Cidara Therapeutics, Inc. (CDTX)

Preclinical(3)

Drug	Company
BXT-25	BIOXYTRAN, INC (BIXT)
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)
ht-tbi	Hoth Therapeutics, Inc. (HOTH)

Phase 4(5)

Drug	Company
Acetylsalicylic acid	Cidara Therapeutics, Inc. (CDTX)
Lidocaine Infusion	Cidara Therapeutics, Inc. (CDTX)
Nefopam 120mg/day infusion	Cidara Therapeutics, Inc. (CDTX)
Tirofiban	Cidara Therapeutics, Inc. (CDTX)
Tirofiban	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 31 drugs in development for Ischemic Stroke across 17 companies.

There are 15 clinical trials targeting Ischemic Stroke tracked by BioSniper.

The estimated prevalence of Ischemic Stroke is approximately 1008.3 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.